MAPT and Alzheimer disease: With incentives getting higher for effective AD-modifying therapies, reviewed herein are advances in tau-reactive antibodies and their role in tau clearance is likely to become an important part of gradually emerging complex solution to this debilitating disease in the foreseeable future.